NMC

NEA Management Company Portfolio holdings

AUM $1.33B
1-Year Return 85.82%
This Quarter Return
+5.74%
1 Year Return
+85.82%
3 Year Return
+531.37%
5 Year Return
+304.32%
10 Year Return
+4,927.96%
AUM
$2.25B
AUM Growth
-$166M
Cap. Flow
+$58.4M
Cap. Flow %
2.6%
Top 10 Hldgs %
71.88%
Holding
46
New
3
Increased
7
Reduced
–
Closed
3

Top Buys

1
GNCA
Genocea Biosciences, Inc.
GNCA
$26.3M
2
ADAP
Adaptimmune Therapeutics
ADAP
$14.7M
3
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
$14.6M
4
CRSP icon
CRISPR Therapeutics
CRSP
$12.1M
5
RARX
Ra Pharmaceuticals, Inc. Common Stock
RARX
$10.6M

Top Sells

1
CASC
Cascadian Therapeutics, Inc.
CASC
$33.5M
2
ORKA
Oruka Therapeutics, Inc. Common Stock
ORKA
$1.97M
3
OREX
Orexigen Therapeutics, Inc.
OREX
$478K

Sector Composition

1 Healthcare 87.61%
2 Technology 5.47%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
PHXM
26
DELISTED
PHAXIAM Therapeutics S.A.. American Depositary Shares
PHXM
$13.1M 0.58%
62,500
– –
RIGL icon
27
Rigel Pharmaceuticals
RIGL
$720M
$11.5M 0.51%
324,315
– –
DZSI
28
DELISTED
DZS Inc. Common Stock
DZSI
$10.9M 0.49%
956,255
– –
ELGX
29
DELISTED
Endologix Inc
ELGX
$10.5M 0.47%
249,020
– –
NITE
30
DELISTED
Nightstar Therapeutics plc American Depositary Shares
NITE
$10.2M 0.45%
714,285
– –
AFMD
31
DELISTED
Affimed
AFMD
$9.51M 0.42%
513,889
+125,000
+32% +$2.31M
TRIL
32
DELISTED
Trillium Therapeutics Inc.
TRIL
$9M 0.4%
1,250,000
– –
TNTR
33
DELISTED
Tintri, Inc. Common Stock
TNTR
$8.98M 0.4%
5,253,358
– –
TCON
34
DELISTED
TRACON Pharmaceuticals, Inc. Common Stock
TCON
$7.98M 0.35%
17,336
+3,540
+26% +$1.63M
RGLS
35
DELISTED
Regulus Therapeutics
RGLS
$7.89M 0.35%
91,583
– –
ARQL
36
DELISTED
Arqule Inc
ARQL
$7.26M 0.32%
2,520,316
– –
MDB icon
37
MongoDB
MDB
$26.2B
$6.51M 0.29%
150,000
– –
TRVN
38
DELISTED
Trevena, Inc.
TRVN
$6.25M 0.28%
6,099
– –
CSBR icon
39
Champions Oncology
CSBR
$95.4M
$5.69M 0.25%
1,562,500
– –
AQ
40
DELISTED
Aquantia Corp. Common Stock
AQ
$3.76M 0.17%
239,587
– –
VIRX
41
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$3.53M 0.16%
37,094
– –
AKTX
42
Akari Therapeutics
AKTX
$23.8M
$823K 0.04%
22,608
– –
AYTU icon
43
AYTU BioPharma
AYTU
$20.3M
$29K ﹤0.01%
+11
New +$29K
ORKA
44
Oruka Therapeutics, Inc. Common Stock
ORKA
$561M
– –
-6,760
Closed -$1.97M
CASC
45
DELISTED
Cascadian Therapeutics, Inc.
CASC
– –
-9,064,575
Closed -$33.5M
OREX
46
DELISTED
Orexigen Therapeutics, Inc.
OREX
– –
-370,900
Closed -$478K
1
2